Supportive Stem Cell Transplant Protocols / Clinical Studies

Non-therapeutic protocols address such issues as side effects or long-term effects of therapy, quality of life, making testing easier on the children, prevention of pain, and issues related to nutrition and stress. There are also tissue and blood banking protocols for laboratory researchers who are studying diseases and searching for underlying causes and cures. The research at St. Jude is designed to include all aspects related to the care of sick children and their families.

 

Protocol for Collecting Long-Term Follow-Up Data on Recipients of Hematopoietic Stem Cell Transplant

 
 

Long-Term Follow-Up of Patients who have Received Gene Therapy/Gene Marked Products

 
 

Peripheral Blood Stem Cells Obtained from Normal Volunteers for Studying Retroviral Vector Mediated Gene Transfer into Primitive Hematopoietic Cells and Vector Mediated Transgene Expression in Mature Hematopoietic Lineages

 
 

Immune Constitution in Oncology Patients Following Autologous Stem Cell Transplant

For: Immune system reconstitution

 
 

Cognitive, Academic and Psychosocial Functioning In Long-Term Survivors of Pediatric Stem Cell Transplantation

 

Non St. Jude Protocols

 

A multicenter access and distribution protocol for unlicensed cryopreserved cord blood units for transplantation in pediatric and adult patients with hematologic malignancies and other indications

 
 

A Phase III Trial of Calfactant for Acute Lung Injury in Pediatric Leukemia and Hematopoietic Stem Cell Transplant Patients

For: acute respiratory distress (ARDS) / acute lung injury (ALI)

 
 

CCL1034/Impact of Cleansing with Chlorhexidine Gluconate (CHG) on Reducing Central Line Associated Bloodstream Infection (CLABSI) and Acquisition of Multi-Drug Resistant Organisms (MDRO) In Children with Cancer or Those Receiving Allogeneic Hematopoietic Cell Transplantation (HCT) (ACL1034)

For: Cancer or allogeneic hematopoietic cell transplantation

 
 

National Marrow Donor Program: A Research Database for Allogeneic Unrelated Hematopoietic Stem Cell Transplantation